Physician profile
Basem Haddad
NPI 1821038886
$10,649.65
in general payments reported to CMS, 2019-2025
33 companies · $7,822 in 2025
The $7,822 reported for 2025 was more than what 91% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $318 · 2020: $355 · 2021: $187 · 2022: $277 · 2023: $908 · 2024: $783 · 2025: $7,822.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $6,000 · Food and Beverage: $3,113 · Education: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $6,000.00 |
| Food and Beverage | $3,112.61 |
| Education | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $6,827.85 | 2025 | Ohtuvayre |
| Inspire Medical Systems, INC. | $805.98 | 2019-2025 | Inspire |
| Glaxosmithkline, LLC. | $436.10 | 2023-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Genzyme Corporation | $384.70 | 2022-2025 | |
| Horizon Therapeutics Plc | $383.53 | 2019-2023 | Krystexxa |
| Astrazeneca Pharmaceuticals LP | $192.91 | 2020-2023 | Fasenra, Lokelma, Farxiga |
| Genentech USA, INC. | $191.04 | 2019-2021 | |
| Baxter Healthcare | $175.84 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Boehringer Ingelheim Pharmaceuticals, INC. | $159.85 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Amgen INC. | $140.05 | 2024 | Krystexxa, Parsabiv, Tavneos |
| Alexion Pharmaceuticals, INC. | $101.00 | 2024 | |
| Insmed, INC. | $92.13 | 2020-2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $86.85 | 2025 | Dupixent |
| Sanofi-Aventis U.S. LLC | $76.99 | 2022 | |
| Jazz Pharmaceuticals INC. | $66.86 | 2019-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $64.49 | 2024 | Yupelri |
| Painteq LLC | $56.19 | 2023 | Painteq |
| Bayer Healthcare Pharmaceuticals INC. | $48.00 | 2023 | |
| Grifols USA, LLC | $42.45 | 2024-2025 | Prolastin-C Liquid |
| Abbvie INC. | $41.42 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $38.14 | 2022-2024 | Lifevest |
| Calliditas Therapeutics US INC. | $36.89 | 2025 | Tarpeyo |
| Novo Nordisk INC | $31.63 | 2023-2024 | Ozempic, Rybelsus |
| Actelion Pharmaceuticals US, INC. | $23.89 | 2024 | Opsumit |
| Viatris Specialty LLC | $22.61 | 2025 | Yupelri |
| Harmony Biosciences LLC | $21.19 | 2020 | |
| Daiichi Sankyo INC. | $18.97 | 2021 | |
| Pfizer INC. | $18.52 | 2020 | |
| Advanced Respiratory, INC | $14.13 | 2021 | |
| Janssen Pharmaceuticals, INC | $14.05 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.73 | 2024 | Eliquis |
| Sunovion Pharmaceuticals INC. | $11.92 | 2020 | |
| Inogen, INC. | $9.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Basem Haddad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.